Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hideaki Nakajima

Showing results (1-10 of 497) with videos related to

Pageof 50
Sort By:
Internal Medicine (Tokyo, Japan)|February 4, 2020
Molecular Pathogenesis and Treatment of Myelodysplastic SyndromesHideaki Nakajima
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 12, 2016
A primer for epigenetics of hematological malignanciesHideaki Nakajima
International Journal of Hematology|May 31, 2017
Guest editorial: Hematopoietic stem cellsHideaki Nakajima
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|September 9, 2021
[Management of conflict of interest in Japanese Society of Hematology]Hideaki Nakajima
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|July 9, 2019
[Genetic abnormalities in AML]Hideaki Nakajima
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 6, 2011
[Signaling pathways regulating hematopoiesis and their roles in hematopoietic malignancies]Hideaki Nakajima
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|September 8, 2016
Application of iPS cells derived from congenital myelodysplastic syndrome for research of nomal hematopoesis and hematological malignanciesHideaki Nakajima
The Keio Journal of Medicine|July 2, 2011
Role of transcription factors in differentiation and reprogramming of hematopoietic cellsHideaki Nakajima
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|September 6, 2023
[Pathogenesis and treatment of immune dysregulation associated with myelodysplastic syndromes]Hideaki Nakajima
Internal Medicine (Tokyo, Japan)|March 8, 2023
COVID-19 Vaccination and the Development of Autoimmune DiseasesRyusuke Yoshimi, Hideaki Nakajima
Pageof 50

Showing results (1-10 of 497) with videos related to

Sort By:
Pageof 50
Internal Medicine (Tokyo, Japan)|February 4, 2020
Molecular Pathogenesis and Treatment of Myelodysplastic SyndromesHideaki Nakajima
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 12, 2016
A primer for epigenetics of hematological malignanciesHideaki Nakajima
International Journal of Hematology|May 31, 2017
Guest editorial: Hematopoietic stem cellsHideaki Nakajima
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|September 9, 2021
[Management of conflict of interest in Japanese Society of Hematology]Hideaki Nakajima
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|July 9, 2019
[Genetic abnormalities in AML]Hideaki Nakajima
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 6, 2011
[Signaling pathways regulating hematopoiesis and their roles in hematopoietic malignancies]Hideaki Nakajima
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|September 8, 2016
Application of iPS cells derived from congenital myelodysplastic syndrome for research of nomal hematopoesis and hematological malignanciesHideaki Nakajima
The Keio Journal of Medicine|July 2, 2011
Role of transcription factors in differentiation and reprogramming of hematopoietic cellsHideaki Nakajima
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|September 6, 2023
[Pathogenesis and treatment of immune dysregulation associated with myelodysplastic syndromes]Hideaki Nakajima
Internal Medicine (Tokyo, Japan)|March 8, 2023
COVID-19 Vaccination and the Development of Autoimmune DiseasesRyusuke Yoshimi, Hideaki Nakajima
Pageof 50